P

Inventor

CHOI HWAN GEUN

KR53 patents
⚠️ This page may combine multiple inventors who share the name “CHOI HWAN GEUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DANA FARBER CANCER INST INC

24 patents
US9505784B2Nov 29, 2016

Fused 2-aminothiazole compounds

DANA FARBER CANCER INST INC64 citations97
US9783504B2Oct 10, 2017

Kinase inhibitors for the treatment of disease

DANA FARBER CANCER INST INC21 citations94
US9358231B2Jun 7, 2016

Type II RAF kinase inhibitors

DANA FARBER CANCER INST INC22 citations91
US10975058B2Apr 13, 2021

Imidazolyl kinase inhibitors and uses thereof

DANA FARBER CANCER INST INC6 citations84
US10544138B2Jan 28, 2020

Tricyclic kinase inhibitors of MELK and methods of use

DANA FARBER CANCER INST INC12 citations84
US10457691B2Oct 29, 2019

Macrocyclic kinase inhibitors and uses thereof

DANA FARBER CANCER INST INC9 citations84
US10316002B2Jun 11, 2019

Kinase inhibitors for the treatment of disease

DANA FARBER CANCER INST INC9 citations84
US10287268B2May 14, 2019

Imidazolyl kinase inhibitors and uses thereof

DANA FARBER CANCER INST INC11 citations84
US10265321B2Apr 23, 2019

Uses of salt-inducible kinase (SIK) inhibitors

DANA FARBER CANCER INST INC10 citations83
US10112957B2Oct 30, 2018

Thiazolyl-containing compounds for treating proliferative diseases

DANA FARBER CANCER INST INC5 citations83
US10233157B2Mar 19, 2019

SIK inhibitor for use in a method of treating an inflammatory and/or immune disorder

DANA FARBER CANCER INST INC9 citations82
US11826365B2Nov 28, 2023

Type II raf kinase inhibitors

DANA FARBER CANCER INST INC1 citations73
US10913744B2Feb 9, 2021

LRRK2 inhibitors and methods of making and using the same

DANA FARBER CANCER INST INC3 citations73
US10464949B2Nov 5, 2019

Thiazolyl-containing compounds for treating proliferative diseases

DANA FARBER CANCER INST INC2 citations72
US10385019B2Aug 20, 2019

Inhibitors of EGFR and methods of use thereof

DANA FARBER CANCER INST INC2 citations72
US10266517B2Apr 23, 2019

Pyrimidines as EGFR inhibitors and methods of treating disorders

DANA FARBER CANCER INST INC2 citations72
US12331037B2Jun 17, 2025

Pyrimidines as EGFR-inhibitors and methods of treating disorders

DANA FARBER CANCER INST INC0 citations62
US12209076B2Jan 28, 2025

Imidazolyl kinase inhibitors and uses thereof

DANA FARBER CANCER INST INC0 citations62
US11673882B2Jun 13, 2023

Pyrimidines as EGFR inhibitors and methods of treating disorders

DANA FARBER CANCER INST INC0 citations62
US10836722B2Nov 17, 2020

Inhibitors of EGFR and methods of use thereof

DANA FARBER CANCER INST INC1 citations62
US10875844B2Dec 29, 2020

Salicylate inhibitors of MELK and methods of use

DANA FARBER CANCER INST INC0 citations51
US10870636B2Dec 22, 2020

Pyrimidines as EGFR inhibitors and methods of treating disorders

DANA FARBER CANCER INST INC0 citations51
US10844077B2Nov 24, 2020

Thiazolyl-containing compounds for treating proliferative diseases

DANA FARBER CANCER INST INC0 citations51
US10508082B2Dec 17, 2019

Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK

DANA FARBER CANCER INST INC0 citations51

SIM TAE BO

5 patents

MASSACHUSETTS GEN HOSPITAL

4 patents

BROAD INST INC

3 patents

DAEGU GYEONGBUK MEDICAL INNOVATION FOUND

3 patents

VORONOI INC

3 patents

KOREA INST SCI & TECH

3 patents

UNIV COURT OF THE UNIV OF DUNDEE

1 patent

CHOI HWAN GEUN

1 patent

SON JUNG BEOM

1 patent

LG CHEMICAL LTD

1 patent

JUNG SEUNG HYUN

1 patent

Showing the top 50 of 53 patents by PatentIndex Score.